Latest Breaking News On - டெப்பி எச்சிசன் - Page 1 : comparemela.com
Share this article
Share this article
JERSEY CITY, N.J., May 12, 2021 /PRNewswire/ Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced it will present findings from a new analysis of claims data from a cohort of patients who received RADICAVA
® (edaravone) for the treatment of amyotrophic lateral sclerosis (ALS). The analysis will be presented during the 2021 European Network to Cure ALS (ENCALS) Meeting, being held virtually May 12-14. Initial insights shared with the scientific community during ENCALS are a part of our wide-ranging efforts to compile real-world data that can be used to learn as much as possible about the clinical experience of RADICAVA, said Gustavo A. Suarez Zambrano, M.D., Vice President of Medical Affairs, MTPA. We utilized a rigorous statistical methodology to comprehensively assess more than two years of administrative claims data for our therapy. Analysis is still ongoing, and we look forward to sharing more details about the methodology
Jersey
Japan
Osaka
United-states
Shoko
Ch-ungch-ong-namdo
South-korea
Canada
Switzerland
America
Gustavoa-suarez-zambrano
Debbie-etchison
Share this article
Share this article
JERSEY CITY, N.J., April 20, 2021 /PRNewswire/ Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of an analysis of the timing of disease progression milestones among commercially insured amyotrophic lateral sclerosis (ALS) patients treated with intravenous (IV) RADICAVA
® (edaravone). The findings are being presented during the 2021 Virtual American Academy of Neurology (AAN) Annual Meeting, held April 17-22. We are pleased to share these data, which may provide information to the ALS community by observing the time to real-world milestones associated with ALS progression, said Gustavo A. Suarez Zambrano, M.D., Vice President of Medical Affairs, MTPA. The results from this new analysis of real-world data gives clinicians more information that may be useful in evaluating treatment for their patients.
Jersey
Japan
Osaka
United-states
Shoko
Ch-ungch-ong-namdo
South-korea
Canada
Switzerland
America
American
Gustavoa-suarez-zambrano